Recent considerations in nonsteroidal anti-inflammatory drug gastropathy

Singh, 1996, Gastrointestinal tract complications of non-steroidal anti-inflammatory drug treatment in rheumatoid arthritis—A prospective observational cohort study, Arch Intern Med, 156, 1530, 10.1001/archinte.1996.00440130066007 Fries, 1986, ARAMIS (The American Rheumatism Association Medical Information System), West J Med, 145, 798 Fries, 1993, A reevaluation of aspirin therapy in rheumatoid arthritis, Arch Intern Med, 153, 2465, 10.1001/archinte.1993.00410210093010 Singh, 1989, Toxic effects of azathioprine in rheumatoid arthritis: a national post-marketing perspective (Abstr.), Arthritis Rheum, 32, 837, 10.1002/j.2326-5205.1989.tb00014.x Singh, 1991, Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis, J Rheumatol, 18, 188 Fries, 1980, Measurement of patient outcome in arthritis, Arthritis Rheum, 23, 137, 10.1002/art.1780230202 Ramey, 1996, The Health Assessment Questionnaire 1995, 227 Buchanan, 1991, Prediction of organ system toxicity with anti-rheumatic drug therapy, 403 Brooks, 1991, Nonsteroidal antiinflammatory drugs—differences and similarities, N Engl J Med, 324, 1716, 10.1056/NEJM199106133242407 Hardin, 1992 Paulus, 1989, Nonsteroidal Anti-inflammatory Drugs, 765 Ehsanullah, 1988, Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs, BMJ, 297, 1017, 10.1136/bmj.297.6655.1017 Caruso, 1980, Gastroscopic evaluation of antiinflammatory agents, BMJ, 280, 75, 10.1136/bmj.280.6207.75 McCarthy, 1989, Nonsteroidal antiinflammatory drug induced ulcers, Gastroenterology, 96, 662, 10.1016/S0016-5085(89)80063-0 Gabriel, 1993, The cost-effectiveness of misoprostol for nonsteroidal antiinflammatory drug-associated adverse gastrointestinal events, Arthritis Rheum, 36, 447, 10.1002/art.1780360404 Gabriel, 1991, Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis, Ann Intern Med, 115, 787, 10.7326/0003-4819-115-10-787 Paulus, 1987, Government affairs. FDA Arthritis Advisory Committee meeting: risks of agranulocytosis/aplastic anemia, flank pain, and adverse gastrointestinal effects with the use of nonsteroidal antiinflammatory drugs, Arthritis Rheum, 30, 593, 10.1002/art.1780300518 Silverstein, 1995, Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial, Ann Intern Med, 123, 241, 10.7326/0003-4819-123-4-199508150-00001 Langman, 1994, Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs, Lancet, 343, 1075, 10.1016/S0140-6736(94)90185-6 Garcia Rodriguez, 1994, Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs, Lancet, 343, 769, 10.1016/S0140-6736(94)91843-0 Singh, 1997, NSAID-related effects on the GI tract: an ever widening spectrum (Abstr.), Gastroenterology, 112, A42 Griffin, 1991, Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons, Ann Intern Med, 114, 257, 10.7326/0003-4819-114-4-257 Armstrong, 1987, Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulcerations, Gut, 28, 527, 10.1136/gut.28.5.527 National Center for Health Statistics. GMWKI: total deaths for each cause by 5-year age groups, United States, 1994 (unpublished data from NCHS website data warehouse). Hyattsville, MD: Public Health Service, 1997. Larkai, 1987, Gastroduodenal mucosa and dyspeptic symptoms in arthritis patients during chronic nonsteroidal anti-inflammatory drug use, Am J Gastroenterol, 82, 1153 Polisson, 1996, Nonsteroidal anti-inflammatory drugs, Am J Med, 100, 31S, 10.1016/S0002-9343(97)89544-7 Lichtenstein, 1995, Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. The double-edged sword, Arthritis Rheum, 38, 5, 10.1002/art.1780380103 Bjorkman, 1996, Nonsteroidal anti-inflammatory drug-induced gastrointestinal injury, Am J Med, 101, 25S, 10.1016/S0002-9343(96)00135-0 Longstreth, 1995, Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage, Am J Gastroenterol, 90, 206 Greene, 1992, Cost-conscious prescribing of nonsteroidal anti-inflammatory drugs for adults with arthritis. A review and suggestions, Arch Intern Med, 152, 1995, 10.1001/archinte.1992.00400220033006 Hallas, 1995, Nonsteroidal anti-inflammatory drugs and upper gastrointestinal bleeding, identifying high-risk groups by excess risk estimates, Scand J Gastroenterol, 30, 438, 10.3109/00365529509093304 Hochain, 1995, Which patients taking non-aspirin nonsteroidal anti-inflammatory drugs bleed? A case-control study, Eur J Gastroenterol Hepatol, 7, 419 Piper, 1991, Corticosteroid use and peptic ulcer disease, Ann Intern Med, 114, 735, 10.7326/0003-4819-114-9-735 Shorr, 1993, Concurrent use of non-steroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease, Arch Intern Med, 153, 1665, 10.1001/archinte.1993.00410140047006 Lanza, 1981, A comparative endoscopic evaluation of damaging effects of nonsteroidal antiinflammatory agents on the gastric and duodenal mucosa, Am J Gastroenterol, 75, 17 Lanza, 1983, Effects of fenbufen, indomethacin, naproxen and placebo on gastric mucosa of normal volunteers, Am J Med, 75, 75, 10.1016/0002-9343(83)90332-7 Lanza, 1984, Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal antiinflammatory drugs, Am J Med, 77, 19, 10.1016/S0002-9343(84)80014-5 Lanza, 1987, An endoscopic comparison of the effects of etodolac, indomethacin, ibuprofen, naproxen, and placebo on the gastrointestinal mucosa, J Rheumatol, 14, 338 Lanza, 1989, An endoscopic comparison of the gastroduodenal injury seen with salsalate and naproxen, J Rheumatol, 16, 1570 Carson, 1987, The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs, Arch Intern Med, 147, 1054, 10.1001/archinte.1987.00370060050010 Fries, 1990, A toxicity index for comparison of side effects among different drugs, Arthritis Rheum, 33, 121, 10.1002/art.1780330117 Fries, 1991, The relative toxicity of non-steroidal anti-inflammatory drugs, Arthritis Rheum, 34, 1353, 10.1002/art.1780341103 Fries, 1993, The relative toxicity of disease modifying antirheumatic drugs (DMARDs), Arthritis Rheum, 36, 297, 10.1002/art.1780360303 Singh, 1993, A toxicity index for comparison of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs (NSAIDs) (Abstr.), Arthritis Rheum, 36, S178 Singh, 1994, Comparative toxicity of non-steroidal anti-inflammatory agents, Pharmacol Ther, 62, 1750, 10.1016/0163-7258(94)90010-8 Robinson, 1989, Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal anti-inflammatory drugs, Dig Dis Sci, 34, 424, 10.1007/BF01536266 Oddsson, 1992, Comparison between ranitidine and omeprazole for protection against gastroduodenal damage caused by naproxen, Scand J Gastroenterol, 27, 1045, 10.3109/00365529209028136 Avorn, 1996, Epidemiologic analysis of prophylactic drug use and NSAID gastropathy (Abstr.), Arthritis Rheum, 39, S165